Establishment and Culture of Human Intestinal Organoids Derived from Adult Stem Cells.


Journal

Current protocols in immunology
ISSN: 1934-368X
Titre abrégé: Curr Protoc Immunol
Pays: United States
ID NLM: 9101651

Informations de publication

Date de publication:
09 2020
Historique:
entrez: 17 9 2020
pubmed: 18 9 2020
medline: 16 6 2021
Statut: ppublish

Résumé

Human intestinal organoids derived from adult stem cells are miniature ex vivo versions of the human intestinal epithelium. Intestinal organoids are useful tools for the study of intestinal physiology as well as many disease conditions. These organoids present numerous advantages compared to immortalized cell lines, but working with them requires dedicated techniques. The protocols described in this article provide a basic guide to establishment and maintenance of human intestinal organoids derived from small intestine and colon biopsies. Additionally, this article provides an overview of several downstream applications of human intestinal organoids. © 2020 The Authors. Basic Protocol 1: Establishment of human small intestine and colon organoid cultures from fresh biopsies Basic Protocol 2: Mechanical splitting, passage, and expansion of human intestinal organoids Alternate Protocol: Differentiation of human intestinal organoids Basic Protocol 3: Cryopreservation and thawing of human intestinal organoids Basic Protocol 4: Immunofluorescence staining of human intestinal organoids Basic Protocol 5: Generation of single-cell clonal intestinal organoid cultures Support Protocol 1: Production of Wnt3A conditioned medium Support Protocol 2: Production of Rspo1 conditioned medium Support Protocol 3: Extraction of RNA from intestinal organoid cultures.

Identifiants

pubmed: 32940424
doi: 10.1002/cpim.106
pmc: PMC9285512
doi:

Substances chimiques

Biomarkers 0
Culture Media, Conditioned 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e106

Subventions

Organisme : Cancer Research UK
ID : C10674/A27140
Pays : United Kingdom

Informations de copyright

© 2020 The Authors.

Références

Nature. 2016 Feb 18;530(7590):340-3
pubmed: 26863187
Nature. 2020 Apr;580(7802):269-273
pubmed: 32106218
Nat Cell Biol. 2018 Aug;20(8):909-916
pubmed: 30038251
Gastroenterology. 2019 Feb;156(3):562-576
pubmed: 30476497
Cell. 2013 Jul 18;154(2):274-84
pubmed: 23870119
Cell. 2015 May 7;161(4):933-45
pubmed: 25957691
Cell. 2018 Sep 6;174(6):1586-1598.e12
pubmed: 30100188
Nat Commun. 2019 Oct 8;10(1):4571
pubmed: 31594944
Cell Stem Cell. 2020 Nov 5;27(5):840-851.e6
pubmed: 32818433
Curr Protoc Immunol. 2020 Sep;130(1):e106
pubmed: 32940424
Nat Rev Immunol. 2020 May;20(5):279-293
pubmed: 31853049
Gastroenterology. 2018 Jul;155(1):130-143.e15
pubmed: 29604290
Cell Stem Cell. 2013 Dec 5;13(6):653-8
pubmed: 24315439
Sci Rep. 2019 May 7;9(1):7029
pubmed: 31065051
Nature. 2016 Oct 13;538(7624):260-264
pubmed: 27698416
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Nature. 2020 Jan;577(7789):254-259
pubmed: 31853059
Nat Protoc. 2015 Oct;10(10):1474-85
pubmed: 26334867
Gastroenterology. 2011 Nov;141(5):1762-72
pubmed: 21889923
Cell. 2016 Jun 16;165(7):1586-1597
pubmed: 27315476
Cell. 2020 Jun 11;181(6):1291-1306.e19
pubmed: 32407674
Nat Med. 2013 Jul;19(7):939-45
pubmed: 23727931
Cell. 2004 Mar 19;116(6):883-95
pubmed: 15035989
Nature. 2015 May 7;521(7550):43-7
pubmed: 25924068
Nat Rev Cancer. 2018 Jul;18(7):407-418
pubmed: 29692415
Cell Stem Cell. 2018 Dec 6;23(6):787-793.e6
pubmed: 30526881
Nature. 2017 May 11;545(7653):234-237
pubmed: 28467818
Sci Rep. 2020 Feb 26;10(1):3535
pubmed: 32103108
Cell Stem Cell. 2020 Apr 2;26(4):503-510.e7
pubmed: 32084388
J Clin Invest. 2014 Jan;124(1):328-37
pubmed: 24292712

Auteurs

Cayetano Pleguezuelos-Manzano (C)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Jens Puschhof (J)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Stieneke van den Brink (S)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Veerle Geurts (V)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Joep Beumer (J)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.

Hans Clevers (H)

Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, The Netherlands.
Oncode Institute, Utrecht, The Netherlands.
The Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH